InsiderTrades

Form 4 for KNSA Kiniksa Pharmaceuticals International, plc

Accepted 2025-11-04 00:00:00 ET · period of report 2025-10-31 · accession 0001741533-25-000003 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-11-04 2025-10-31 KNSA Paolini John F. Chief MEDICAL Off M - OptEx $6.60 +82.5K 143.9K +135% +$545.0K
D 2025-11-04 2025-10-31 KNSA Paolini John F. Chief MEDICAL Off S - Sale+OE $37.14 -82.5K 61.3K -57% -$3.07M
DM 2025-11-04 2025-10-31 KNSA Paolini John F. Chief MEDICAL Off M - OptEx $0.00 -82.5K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Ordinary Share 2025-10-31 M A 36,542 $3.80 97,866 D — —
2 Common Class A Ordinary Share 2025-10-31 M A 46,000 $8.83 143,866 D — —
3 Common Class A Ordinary Share 2025-10-31 S D 82,542 $37.14 61,324 D — — (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $36.80 and $37.675. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
4 Derivative Share Option 2025-10-31 M D 36,542 $0.00 0 D $3.80 · — to 2027-06-28 36,542 Class A Ordinary Share (F3) The option is fully vested and exercisable.
5 Derivative Share Option 2025-10-31 M D 46,000 $0.00 0 D $8.83 · — to 2029-09-16 46,000 Class A Ordinary Share (F3) The option is fully vested and exercisable.